Antineoplastics
- Cancer drugs span cytotoxic + targeted therapy
- Selection is tumor-, stage- + biomarker-specific
- Cytotoxics damage dividing cells broadly
- Targeted drugs exploit defined tumor pathways
- Immunotherapy releases antitumor immunity
- Toxicity patterns differ more than efficacy class
- Do not generalize one cancer drug to another
Class at a glance
- Cancer drugs span cytotoxic + targeted therapy
Safety / monitoring
- Toxicity patterns differ more than efficacy class
Clinical role
- Selection is tumor-, stage- + biomarker-specific
- Targeted drugs exploit defined tumor pathways
- Immunotherapy releases antitumor immunity
- Do not generalize one cancer drug to another
Practical pearls
- Cytotoxics damage dividing cells broadly
Drugs in this class (52)
All drug classes · Open the interactive console ↗